Ron-El R, Caspi E, Herman A, Schreyer P, Algom M, Schlezinger Z
Obstet Gynecol. 1983 Mar;61(3 Suppl):10S-12S.
Premature uterine contractions were treated by intravenous beta-mimetics in 190 patients during a 2-year period. History and physical examination were directed toward identification of patients with cardiac problems. Unexpected cardiac pathology was discovered in 14 patients, all of whom exhibited severe and continuous nausea, retrosternal pain, or dyspnea during beta-mimetic administration. Treatment was immediately discontinued in the presence of S-T depression, supraventricular tachycardia, nonspecific T wave changes, and sinus tachycardia with right axis deviation. Further investigation revealed obstructive cardiac myopathy in one case and atrial septal defect in another. Such changes might be identified earlier by more extensive screening procedures (such as electrocardiogram) before drug administration. Administration of beta-mimetic agents may uncover previously unexpected cardiac pathology. Continuation of ritodrine in such cases is contraindicated and potentially hazardous.
在两年期间,190例患者采用静脉注射β-拟交感神经药治疗早产子宫收缩。病史和体格检查旨在识别有心脏问题的患者。14例患者发现了意外的心脏病变,所有这些患者在使用β-拟交感神经药期间均出现严重且持续的恶心、胸骨后疼痛或呼吸困难。出现S-T段压低、室上性心动过速、非特异性T波改变以及伴有右轴偏移的窦性心动过速时,立即停止治疗。进一步检查发现1例为梗阻性心肌病,另1例为房间隔缺损。在给药前通过更广泛的筛查程序(如心电图)可能更早地识别出此类变化。使用β-拟交感神经药可能会发现先前未预料到的心脏病变。在这种情况下继续使用利托君是禁忌的,且有潜在危险。